Citation Impact
Citing Papers
Modern treatment of haemophilia.
1995
Hemophilia in the 1990s: Principles of Management and Improved Access to Care
1992
A pilot phase II study of the safety and immunogenicity of HIV p17/p24:VLP (p24-VLP) in asymptomatic HIV seropositive subjects
1997
Tolerability of different oral iron supplements: a systematic review
2012
HIV-1 Nef Induces Dendritic Cell Differentiation: A Possible Mechanism of Uninfected CD4+ T Cell Activation
2002
Recombinant Human Immunodeficiency Pr55gagVirus-like Particles Presenting Chimeric Envelope Glycoproteins Induce Cytotoxic T-Cells and Neutralizing Antibodies
1997
Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B
1992
Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF
2016
Current practice in the management of muscle haematomas in patients with severe haemophilia
2010
Functional recovery after bleeding episodes in haemophilia
2004
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Immune reconstitution
2002 StandoutNobel
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
The Relationship between T Cell Proliferative Responses and Plasma Viremia during Treatment of Human Immunodeficiency Virus Type 1 Infection with Combination Antiretroviral Therapy
2000
Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies?
1992
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis
2015 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations
2011
Randomised, Placebo-Controlled, Phase I/IIa Evaluation of the Safety and Immunogenicity of Fowlpox Virus Expressing HIV gag-pol and Interferon-? in HIV-1 Infected Subjects
2005 StandoutNobel
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Presentation of SIVgag to monkey T cells using dendritic cells transfected with a recombinant adenovirus
2000 StandoutNobel
HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Platelet Dysfunction and End‐Stage Renal Disease
2006
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
2006 Standout
Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus
2006 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
HIV-1 Antigen–specific and –nonspecific B Cell Responses Are Sensitive to Combination Antiretroviral Therapy
1998
Increased Macrophage Infection upon Subcutaneous Inoculation of Rhesus Macaques with Simian Immunodeficiency Virus-Loaded Dendritic Cells or T Cells but Not with Cell-Free Virus
2002 StandoutNobel
Temporal Analyses of Virus Replication, Immune Responses, and Efficacy in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine
1998
Guanidino compounds in uraemic dialysed patients
1986
Pharmacokinetics of Coagulation Factors
2001
Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion
1993
Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
1994 Standout
Quarantine versus pathogen‐reduced plasma‐coagulation factor content and rotational thromboelastometry coagulation
2016
Recombinant Factor IX Recovery and Inhibitor Safety: A Canadian Post-licensure Surveillance Study
2002
Endogenously Expressed nef Uncouples Cytokine and Chemokine Production from Membrane Phenotypic Maturation in Dendritic Cells
2002 StandoutNobel
Guidelines for the management of hemophilia
2012 Standout
The Decreased Replicative Capacity of Simian Immunodeficiency Virus SIVmac239ΔnefIs Manifest in Cultures of Immature Dendritic Cells and T Cells
2000 StandoutNobel
Dendritic Cells, Infected with Vesicular Stomatitis Virus-Pseudotyped HIV-1, Present Viral Antigens to CD4+ and CD8+ T Cells from HIV-1-Infected Individuals
2000 StandoutNobel
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
1994 Standout
Creatine and Creatinine Metabolism
2000 Standout
Works of A. Aronstam being referenced
Improvement of platelet function by increased frequency of hemodialysis.
1978
Patterns of bleeding in adolescents with severe haemophilia A.
1979
Antibodies to HIV-1 nef (p27): Prevalence, Significance, and Relationship to Seroconversion
1990
A double-blind controlled trial of two dose levels of factor VIII in the treatment of high risk haemarthroses in haemophilia A
1983
Low doses of factor VIII for selected ankle bleeds in severe haemophilia A.
1982
Hemophilic patients with an inhibitor to factor VIII treated with high dose factor VIII concentrate. Results of a collaborative study for the evaluation of factor VIII inhibitor titer, recovery and half life of infused factor VIII.
1986
The identification of high-risk elbow hemorrhages in adolescents with severe hemophilia A
1981
A comparative trial of a controlled-release iron tablet preparation ('Ferrocontin' Continus) and ferrous fumarate tablets.
1982
Prophylaxis in Haemophilia: A Double‐blind Controlled Trial
1976
The clinical features of early bleeding into the muscles of the lower limb in severe haemophiliacs
1983
DOUBLE-BLIND CONTROLLED TRIAL OF THREE DOSAGE REGIMENS IN TREATMENT OF HÆMARTHROSES IN HÆMOPHILIA A
1980
The relationship between coagulation factor VIII and ABO blood group status.
1988
Effect of height and weight on the in vivo recovery of transfused factor VIII C.
1982
Twice weekly prophylactic therapy in haemophilia A.
1977
Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection.
1991
Early bleeding into upper limb muscles in severe haemophilia. Clinical features and treatment
1987